dr. rugo on anti-angiogenesis therapy response predictors
Published 12 years ago • 244 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
0:59
dr. rugo on vegf-a as an avastin response predictor
-
0:56
dr. rugo on proliferation as an anti-angiogenesis marker
-
1:15
dr. rugo discusses the future of angiogenesis in breast cancer
-
1:36
dr. rugo on the efficacy of bevacizumab in breast cancer
-
1:53
dr. hope rugo examines angiogenesis inhibition for advanced breast cancer
-
1:20
dr. rugo on hormone therapy for patients with breast cancer
-
0:55
dr. rugo on the future of extended adjuvant hormone therapy for breast cancer
-
1:24
dr. rugo on extended adjuvant hormone therapy for breast cancer
-
1:06
dr. rugo on guidelines for the treatment of metastatic breast cancer
-
1:52
dr. rugo on swish trial for hr-positive breast cancer
-
0:42
dr. fakih on anti-angiogenesis versus anti-egfr therapy in colon cancer
-
0:59
dr. rugo on pi3k and mtor inhibitors for the treatment of breast cancer
-
1:52
dr. rugo on recent updates with immunotherapy in tnbc
-
1:30
dr. hope rugo on trastuzumab biosimilar in her2-positive breast cancer
-
1:26
dr. rugo on rationale for the elaine study in esr1-mutated er /her2- breast cancer
-
1:11
dr. rugo on the significance of the monarch i trial for breast cancer
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
0:32
dr. eng: continuation of anti-angiogenesis therapy
-
1:35
dr. mcdonald discusses resistance to angiogenesis inhibitors